Prescription drug · ANDA
Albendazole NDC 72162-2359
Albendazole 200 mg/1 · Tablet · Oral · Bryant Ranch Prepack
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 72162-2359-2 | 72162235902 | 2 TABLET in 1 BOTTLE (72162-2359-2)Marketed from Jun 28, 2024 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Albendazole
- Generic name (nonproprietary)
- albendazole
- Active ingredients
- Albendazole — 200 mg/1
- Dosage form
- Tablet
- Route
- Oral
- Labeler
- Bryant Ranch Prepack
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 213435
- Marketing start
- Listing expires
- Other FDA classes
- Cytochrome P450 1A Inducers (Mechanism)
- Identifiers
- Product ID 72162-2359_875c188d-cbe0-410c-89c3-3e97a79c2d12SPL ID 875c188d-cbe0-410c-89c3-3e97a79c2d12SPL set ID 74aeb307-b408-47b1-bd8f-fe7eeb844466RxCUI 199672UNII F4216019LN
- Pharmacologic class
- Anthelmintic
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N472162235902followed by a unit qualifier and the quantityPackage 72162-2359-02. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
Albendazole tablet is an anthelmintic drug indicated for: Treatment of parenchymal neurocysticercosis due to active lesions caused by larval forms of the pork tapeworm, Taenia solium . ( 1.1 ) Treatment of cystic hydatid disease of the liver, lung, and peritoneum, caused by the larval form of the dog tapeworm, Echinococcus granulosus . ( 1.2 ) 1.1 Neurocysticercosis Albendazole tablets are indicated for the treatment of parenchymal neurocysticercosis due to active lesions caused by larval forms of the pork tapeworm, Taenia solium . 1.2 Hydatid Disease Albendazole tablets are indicated for the treatment of cystic hydatid disease of the liver, lung, and peritoneum, caused by the larval form of…
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 213435
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Albendazole | Albendazole 200 mg/1 | TabletOral | Novadoz Pharmaceuticals LLC | 72205-051 |